Alopecia areata
MONDO:0005340Loss of scalp and body hair involving microscopically inflammatory patchy areas.
Also known as: alopecia areata, alopecia circumscripta, patchy loss of hair
64 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
New drug aimed at regrowing hair in severe alopecia
Disease control TerminatedThis study tested a drug called amlitelimab in 166 adults with severe alopecia areata, a condition causing significant hair loss. Participants received either the drug or a placebo by injection. The main goal was to see if the drug could reduce hair loss scores after 36 weeks. Th…
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New pill shows promise for severe baldness, but trial cut short
Disease control TerminatedThis study tested a drug called KL130008 in 114 adults with severe alopecia areata, a condition causing major hair loss. The goal was to see if the drug could safely regrow hair, measured by how many people achieved 80% or more scalp coverage. However, the trial was terminated ea…
Phase: PHASE2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Hair loss ointment study halted early – only 4 people enrolled
Disease control TerminatedThis study tested a custom ointment called DPCP to help people with severe alopecia areata, a condition causing patchy or complete scalp hair loss. The goal was to see if the ointment could safely regrow hair. Only 4 people took part before the study was stopped early, so results…
Phase: PHASE3 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC